Regeneron Pharmaceuticals, Inc. (BIT:1REGN)

Ligand Pharmaceuticals Statistics

Total Valuation

BIT:1REGN has a market cap or net worth of EUR 49.43 billion. The enterprise value is 36.74 billion.

Market Cap	49.43B
Enterprise Value	36.74B

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	May 19, 2025

Share Statistics

Current Share Class	101.87M
Shares Outstanding	n/a
Shares Change (YoY)	-1.75%
Shares Change (QoQ)	-2.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	97.91M

Valuation Ratios

The trailing PE ratio is 13.02 and the forward PE ratio is 13.30.

PE Ratio	13.02
Forward PE	13.30
PS Ratio	4.08
PB Ratio	1.94
P/TBV Ratio	2.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.52, with an EV/FCF ratio of 11.19.

EV / Earnings	9.68
EV / Sales	3.02
EV / EBITDA	9.52
EV / EBIT	10.84
EV / FCF	11.19

Financial Position

The company has a current ratio of 4.60, with a Debt / Equity ratio of 0.09.

Current Ratio	4.60
Quick Ratio	3.57
Debt / Equity	0.09
Debt / EBITDA	0.60
Debt / FCF	0.70
Interest Coverage	108.11

Financial Efficiency

Return on equity (ROE) is 15.34% and return on invested capital (ROIC) is 7.78%.

Return on Equity (ROE)	15.34%
Return on Assets (ROA)	6.66%
Return on Invested Capital (ROIC)	7.78%
Return on Capital Employed (ROCE)	11.45%
Revenue Per Employee	797,220
Profits Per Employee	250,066
Employee Count	15,106
Asset Turnover	0.38
Inventory Turnover	2.46

Taxes

In the past 12 months, BIT:1REGN has paid 354.39 million in taxes.

Income Tax	354.39M
Effective Tax Rate	8.54%

Stock Price Statistics

The stock price has decreased by -53.34% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-53.34%
50-Day Moving Average	466.67
200-Day Moving Average	594.81
Relative Strength Index (RSI)	48.53
Average Volume (20 Days)	13

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.91

Income Statement

In the last 12 months, BIT:1REGN had revenue of EUR 12.10 billion and earned 3.80 billion in profits. Earnings per share was 33.78.

Revenue	12.10B
Gross Profit	5.73B
Operating Income	3.37B
Pretax Income	4.15B
Net Income	3.80B
EBITDA	3.80B
EBIT	3.37B
Earnings Per Share (EPS)	33.78

Balance Sheet

The company has 6.36 billion in cash and 2.30 billion in debt, giving a net cash position of 12.62 billion.

Cash & Cash Equivalents	6.36B
Total Debt	2.30B
Net Cash	12.62B
Net Cash Per Share	n/a
Equity (Book Value)	25.49B
Book Value Per Share	244.85
Working Capital	11.23B

Cash Flow

In the last 12 months, operating cash flow was 4.04 billion and capital expenditures -757.66 million, giving a free cash flow of 3.28 billion.

Operating Cash Flow	4.04B
Capital Expenditures	-757.66M
Free Cash Flow	3.28B
FCF Per Share	n/a

Margins

Gross margin is 47.35%, with operating and profit margins of 27.84% and 31.37%.

Gross Margin	47.35%
Operating Margin	27.84%
Pretax Margin	34.30%
Profit Margin	31.37%
EBITDA Margin	31.42%
EBIT Margin	27.84%
FCF Margin	27.11%

Dividends & Yields

This stock pays an annual dividend of 1.63, which amounts to a dividend yield of 0.34%.

Dividend Per Share	1.63
Dividend Yield	0.34%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	4.18%
Buyback Yield	1.75%
Shareholder Yield	2.09%
Earnings Yield	7.68%
FCF Yield	6.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIT:1REGN has an Altman Z-Score of 8.61 and a Piotroski F-Score of 4.

Altman Z-Score	8.61
Piotroski F-Score	4